Related Experiment Video
Updated: Jul 17, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Acute neurovascular unit protection by simvastatin in transient cerebral ischemia
Tavarekere N Nagaraja1, Robert A Knight, Richard L Croxen
1Department of Anesthesiology, Henry Ford Health System, Detroit, MI 48202, USA. annta@neuro.hfh.edu
Abstract:
Acute vascular- and neuroprotective effects of simvastatin were evaluated in a rat model of transient, focal cerebral ischemia. Male, Wistar rats (n=12) underwent transient middle cerebral artery (MCA) occlusion for 3 hours followed by 3 hours of reperfusion. After 30 minutes of MCA occlusion, four rats each were subcutaneously injected with either 20 or 40 mg/kg of simvastatin. At the end of 3 hours of reperfusion, tissue injury and blood-brain barrier (BBB) opening were quantified by histology and [(14)C]-alpha-aminoisobutyric acid (AIB)-based quantitative autoradiography (QAR), respectively. Compared with untreated rats, those treated with simvastatin (20 mg/kg) had reduced volumes of AIB leakage, tissue pallor and distribution space for AIB (p<0.05). No additional effects were seen with the higher drug dose (40 mg/kg). These data suggest that the acute neuroprotective effects of statins are in part owing to attenuation of stroke-induced changes in BBB permeability.
Insights
Simvastatin demonstrated acute neuroprotective effects in a rat stroke model by reducing blood-brain barrier (BBB) opening. The 20 mg/kg dose was effective, suggesting BBB permeability attenuation contributes to statin neuroprotection.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiovascular Research
Background:
- Stroke is a leading cause of death and disability.
- Statins are primarily known for cholesterol-lowering effects.
- Emerging evidence suggests potential neuroprotective roles for statins.
Purpose of the Study:
- To investigate the acute vascular and neuroprotective effects of simvastatin in a rat model of focal cerebral ischemia.
- To determine the impact of simvastatin on blood-brain barrier (BBB) permeability following ischemic stroke.
Main Methods:
- Transient middle cerebral artery (MCA) occlusion was induced in Wistar rats for 3 hours, followed by 3 hours of reperfusion.
- Simvastatin (20 or 40 mg/kg) was administered subcutaneously after 30 minutes of MCA occlusion.
- Tissue injury and BBB opening were quantified using histology and [(14)C]-alpha-aminoisobutyric acid (AIB)-based quantitative autoradiography (QAR).
Main Results:
- Simvastatin treatment (20 mg/kg) significantly reduced AIB leakage, tissue pallor, and AIB distribution space compared to untreated controls (p<0.05).
- No additional benefits were observed with the higher simvastatin dose (40 mg/kg).
- The findings indicate a dose-dependent effect of simvastatin on reducing ischemic brain injury markers.
Conclusions:
- Acute administration of simvastatin exhibits neuroprotective effects in a rat model of focal cerebral ischemia.
- Simvastatin's neuroprotection appears to be partly mediated by attenuating stroke-induced increases in BBB permeability.
- These findings highlight a potential therapeutic benefit of statins beyond their lipid-lowering properties in acute stroke management.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
